The situation regarding avian influenza continues to evolve in Europe and globally, with reports of new outbreaks in birds and occasional infections in mammals. Sporadic human infections have been reported in countries outside the EU, while the risk to the public in the EU remains low.
As of 3 March 2023, ECDC will de-escalate BA.2, BA.4 and BA.5 from its list of SARS-CoV-2 variants of concern (VOC), as these parental lineages are no longer circulating.
In February 2023, Cambodia reported a family cluster in Sithor Kandal district, Prey Veng province, with two people (a girl and her father) infected with avian influenza A(H5N1) virus.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
ECDC recommends that healthcare facilities maintain and strengthen infection prevention and control (IPC) measures, due to the high community transmission and co-circulation of respiratory viruses such as SARS-CoV-2, influenza, respiratory syncytial virus (RSV) and others. The implementation should be based on an approach that considers all these viruses.
In a Threat Assessment Brief released today, the European Centre for Disease Prevention and Control (ECDC) assesses the overall level of risk to the EU/EEA associated with the spread of the Omicron XBB.1.5 SARS-CoV-2 sub-lineage as low for the general population.
Europe has agreed on measures to be applied in aviation in response to the specific localised worsening of the COVID-19 epidemiological situation in China, making recommendations which could potentially also be applied in other geographical regions in similar situations.
XBB.1.5 is a sub-lineage of the SARS-CoV-2 lineage XBB, and is currently estimated to have a large growth advantage over previously circulating lineages in North America (109%) and Europe (113%).